{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:47:31Z","timestamp":1768366051504,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Androgens from the black market are often produced in clandestine laboratories without adherence to hygienic manufacturing processes. Consequently, users may face an increased risk of developing injection-related infections caused by microbiological contamination. This study aimed to determine the presence of microbiological contamination in androgens from the black market.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Characteristics of submitted androgen product were registered. Androgen products were submitted to aerobic and anaerobic bacterial culture using direct inoculation of agar plates and enrichment using BD BACTEC\u2122 Peds Plus Medium blood culture bottles. Participants who submitted products were monitored for injection-related infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bacterial contamination was detected in two of 22 used multidose vials (9%) and one of 41 unused ampules and multidose vials (2%). Identified species included\n                      <jats:italic>Bacillus spp.<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcus warneri<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcus saprophyticus<\/jats:italic>\n                      and\n                      <jats:italic>Micrococcus luteus<\/jats:italic>\n                      . None of the participants developed injection-related infections linked to contaminated products.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both used and unused androgens from the black market can contain bacteria. This can put users at risk for serious injection-related health problems such as abscesses. This study underlines the importance of warning androgen users about these underrecognized injection-related risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Study number: NL77191.028.21. Registration date: 2 June 2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01359-w","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:35:24Z","timestamp":1764909324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiological contamination in androgens from the black market"],"prefix":"10.1186","volume":"23","author":[{"given":"T. J.","family":"Verdegaal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J. H. M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Peijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Huyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. J. M.","family":"Stohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"de Ronde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"publisher","first-page":"1059473","DOI":"10.3389\/fendo.2022.1059473","volume":"13","author":"P Bond","year":"2022","unstructured":"Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: how do they work and what are the risks? Front Endocrinol (Lausanne). 2022;13:1059473. https:\/\/doi.org\/10.3389\/fendo.2022.1059473.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1359_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12954-021-00550-z","volume":"18","author":"J McVeigh","year":"2021","unstructured":"McVeigh J, Hearne E, Boardley I, Bates G, Hope V, Ralphs R, van Hout MC. Generating evidence on the use of image and performance-enhancing drugs in the UK: results from a scoping review and expert consultation by the anabolic steroid UK network. Harm Reduct J. 2021;18(1):107. https:\/\/doi.org\/10.1186\/s12954-021-00550-z.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1359_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/sms.13843","volume":"30","author":"DL Smit","year":"2020","unstructured":"Smit DL, Buijs MM, de Hon O, den Heijer M, de Ronde W. Positive and negative side effects of androgen abuse. The HAARLEM study: a one-year prospective cohort study in 100 men. Scand J Med Sci Sports. 2020;30(3):531\u20139. https:\/\/doi.org\/10.1111\/sms.13843.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"1359_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1017\/S0950268814000727","volume":"143","author":"VD Hope","year":"2015","unstructured":"Hope VD, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergard A, Parry J, Ncube F. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking. Epidemiol Infect. 2015;143(1):132\u201340. https:\/\/doi.org\/10.1017\/S0950268814000727.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"1359_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/09595230802392568","volume":"27","author":"B Larance","year":"2008","unstructured":"Larance B, Degenhardt L, Copeland J, Dillon P. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev. 2008;27(6):679\u201386. https:\/\/doi.org\/10.1080\/09595230802392568.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"1359_CR6","first-page":"167","volume":"76","author":"DL Smit","year":"2018","unstructured":"Smit DL, de Ronde W. Outpatient clinic for users of anabolic androgenic steroids: an overview. Neth J Med. 2018;76(4):167\u201375.","journal-title":"Neth J Med"},{"issue":"3","key":"1359_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5694\/j.1326-5377.1993.tb137813.x","volume":"159","author":"RJ Cooper","year":"1993","unstructured":"Cooper RJ, Kirk JW, Bielenberg P. Mycobacterial infection associated with the use of an anabolic steroid. Med J Aust. 1993;159(3):216. https:\/\/doi.org\/10.5694\/j.1326-5377.1993.tb137813.x.","journal-title":"Med J Aust"},{"issue":"1","key":"1359_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2255-4971(15)30185-3","volume":"46","author":"NS Filho","year":"2011","unstructured":"Filho NS, Gaspar EF, Siqueira KL, Monteiro GC, Andreoli CV, Ejnisman B, Cohen M. Pyomyositis in athletes after the use of anabolic steroids: case reports. Rev Bras Ortop. 2011;46(1):97\u2013100. https:\/\/doi.org\/10.1016\/S2255-4971(15)30185-3.","journal-title":"Rev Bras Ortop"},{"issue":"9","key":"1359_CR9","doi-asserted-by":"publisher","first-page":"e1040","DOI":"10.1097\/GOX.0000000000001040","volume":"4","author":"O Friedman","year":"2016","unstructured":"Friedman O, Arad E, Ben Amotz O. Body builder\u2019s nightmare: black market steroid injection gone wrong: a case report. Plast Reconstr Surg Glob Open. 2016;4(9):e1040. https:\/\/doi.org\/10.1097\/GOX.0000000000001040.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"7","key":"1359_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMicm062498","volume":"355","author":"OP Gautschi","year":"2006","unstructured":"Gautschi OP, Zellweger R. Methicillin-resistant Staphylococcus aureus abscess after intramuscular steroid injection. N Engl J Med. 2006;355(7):713. https:\/\/doi.org\/10.1056\/NEJMicm062498.","journal-title":"N Engl J Med"},{"issue":"9","key":"1359_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ijid.2010.05.012","volume":"14","author":"D Grant","year":"2010","unstructured":"Grant D, Dearing G, Ghosh S, Collier J, Bal C. Necrotizing myositis of the deltoid following intramuscular injection of anabolic steroid. Int J Infect Dis. 2010;14(9):823\u20134. https:\/\/doi.org\/10.1016\/j.ijid.2010.05.012.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"1359_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-2007-963708","volume":"21","author":"G Kienbacher","year":"2007","unstructured":"Kienbacher G, Maurer-Ertl W, Glehr M, Feierl G, Leithner A. A case of a tumor-simulating expansion caused by anabolic androgen steroids in bodybuilding. Sportverletz Sportschaden. 2007;21(4):195\u20138. https:\/\/doi.org\/10.1055\/s-2007-963708.","journal-title":"Sportverletz Sportschaden"},{"issue":"1","key":"1359_CR13","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1308\/rcsann.2013.95.5.e12a","volume":"95","author":"R Pai","year":"2013","unstructured":"Pai R, Parampalli U, Hettiarachni G, Ahmed I. Mycobacterium fortuitum skin infection as a complication of anabolic steroids: a rare case report. Ann R Coll Surg Engl. 2013;95(1):e12\u20133. https:\/\/doi.org\/10.1308\/rcsann.2013.95.5.e12a.","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"1359_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00005768-199902000-00001","volume":"31","author":"JD Rich","year":"1999","unstructured":"Rich JD, Dickinson BP, Flanigan TP, Valone SE. Abscess related to anabolic-androgenic steroid injection. Med Sci Sports Exerc. 1999;31(2):207\u20139. https:\/\/doi.org\/10.1097\/00005768-199902000-00001.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"1359_CR15","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.jemermed.2011.06.008","volume":"44","author":"JR Shiber","year":"2013","unstructured":"Shiber JR. Pyomyositis due to anabolic steroid injection. J Emerg Med. 2013;44(1):e69\u201370.","journal-title":"J Emerg Med"},{"issue":"2","key":"1359_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1001\/jama.1989.03430020049017","volume":"262","author":"MJ Scott","year":"1989","unstructured":"Scott MJ, Scott MJ Jr. HIV infection associated with injections of anabolic steroids. JAMA. 1989;262(2):207\u20138. https:\/\/doi.org\/10.1001\/jama.1989.03430020049017.","journal-title":"JAMA"},{"issue":"26","key":"1359_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1056\/NEJM198412273112615","volume":"311","author":"HM Slarek","year":"1984","unstructured":"Slarek HM, Mantovani RP, Erens E, Heisler D, Niederman MS, Fein AM. AIDS in a bodybuilder using anabolic steroids. N Engl J Med. 1984;311(26):170. https:\/\/doi.org\/10.1056\/NEJM198412273112615.","journal-title":"N Engl J Med"},{"issue":"9","key":"1359_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1572-0241.1998.01598.x","volume":"93","author":"JD Rich","year":"1998","unstructured":"Rich JD, Dickinson BP, Merriman N, Flanigan TP. Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter. Am J Gastroenterol. 1998;93(9):1598. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.01598.x.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1359_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0091450921998701","volume":"48","author":"G Bates","year":"2021","unstructured":"Bates G, McVeigh J, Leavey C. Looking beyond the provision of injecting equipment to people who use anabolic androgenic steroids: harm reduction and behavior change goals for UK policy. Contemp Drug Probl. 2021;48(2):135\u201350. https:\/\/doi.org\/10.1177\/0091450921998701.","journal-title":"Contemp Drug Probl"},{"issue":"1","key":"1359_CR20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1186\/s12889-022-13734-4","volume":"22","author":"R Magnolini","year":"2022","unstructured":"Magnolini R, Falcato L, Cremonesi A, Schori D, Bruggmann P. Fake anabolic androgenic steroids on the black market: a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health. 2022;22(1):1371. https:\/\/doi.org\/10.1186\/s12889-022-13734-4.","journal-title":"BMC Public Health"},{"issue":"3","key":"1359_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/dta.30","volume":"1","author":"MR Graham","year":"2009","unstructured":"Graham MR, Ryan P, Baker JS, Davies B, Thomas NE, Cooper SM, Evans P, Easmon S, Walker CJ, Cowan D, Kicman T. Counterfeiting in performance- and image-enhancing drugs. Drug Test Anal. 2009;1(3):135\u201342. https:\/\/doi.org\/10.1002\/dta.30.","journal-title":"Drug Test Anal"},{"key":"1359_CR22","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.jpba.2022.100101","volume":"219","author":"LM Berneira","year":"2022","unstructured":"Berneira LM, Poletti T, da Silva CC, Garcia MO, Goulart NL, Pereira CMP. Chemical and cytotoxicity evaluation of apprehended formulations of anabolic androgenic steroids. J Pharm Biomed Anal. 2022;219:100101. https:\/\/doi.org\/10.1016\/j.jpba.2022.100101.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1359_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1128\/jcm.30.2.261-264.1992","volume":"30","author":"U Kamath","year":"1992","unstructured":"Kamath U, Singer C, Isenberg HD. Clinical significance of Staphylococcus Warneri bacteremia. J Clin Microbiol. 1992;30(2):261\u20134. https:\/\/doi.org\/10.1128\/jcm.30.2.261-264.1992.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1359_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/antibiotics13100972","volume":"13","author":"S Ravaioli","year":"2024","unstructured":"Ravaioli S, De Donno A, Bottau G, Campoccia D, Maso A, Dolzani P, Balaji P, Pegreffi F, Daglia M, Acriola CR. The opportunistic pathogen Staphylococcus warneri: virulence and antibiotic Resistance, clinical Features, association with orthopedic implants and other medical devices, and a glance at industrial applications. Antibiotics. 2024;13(10):972. https:\/\/doi.org\/10.3390\/antibiotics13100972.","journal-title":"Antibiotics"},{"key":"1359_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5183","author":"A Matarneh","year":"2021","unstructured":"Matarneh A, Ali GA, Goravey W. Pyelonephritis-associated Staphylococcus saprophyticus bacteremia in an immunocompetent host: case report and review of the literature. Clin Case Rep. 2021. https:\/\/doi.org\/10.1002\/ccr3.5183.","journal-title":"Clin Case Rep"},{"issue":"11","key":"1359_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2217\/fmb.15.98","volume":"10","author":"S Kleinschmidt","year":"2015","unstructured":"Kleinschmidt S, Huygens F, Faoagali J, Rathnayake IU, Hafner LM. Staphylococcus epidermidis as a cause of bacteremia. Fut Microbiol. 2015;10(11):1859\u201379. https:\/\/doi.org\/10.2217\/fmb.15.98.","journal-title":"Future Microbiol"},{"issue":"3","key":"1359_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.33073\/pjm-2021-030","volume":"70","author":"M Zhu","year":"2021","unstructured":"Zhu M, Zhu Q, Yang Z, Liang Z. Clinical characteristics of patients with micrococcus luteus bloodstream infection in a Chinese Tertiary-Care hospital. Pol J Microbiol. 2021;70(3):321\u20136. https:\/\/doi.org\/10.33073\/pjm-2021-030.","journal-title":"Pol J Microbiol"},{"issue":"9","key":"1359_CR28","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/sms.13592","volume":"29","author":"DL Smit","year":"2019","unstructured":"Smit DL, de Hon O, Venhuis BJ, den Heijer M, de Ronde W. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids. Scand J Med Sci Sports. 2019;29(9):1432\u201340. https:\/\/doi.org\/10.1111\/sms.13592.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"1359_CR29","first-page":"99","volume":"110","author":"WJ Plaus","year":"1991","unstructured":"Plaus WJ, Hermann G. The surgical management of superficial infections caused by atypical mycobacteria. Surgery. 1991;110(1):99\u2013105.","journal-title":"Surgery"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01359-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01359-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01359-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:06:07Z","timestamp":1768341967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01359-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01359-w","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and informed consent was approved by the Institutional Review Board (study number: NL77191.028.21) in June 2021 after which inclusion of subjects started.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants in this study signed informed consent for their participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and approved the final manuscript for submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}